PegIFN alpha-2a reduces relapse in HBeAg-negative patients after nucleo(s)tide analogue cessation: A randomized-controlled trial.
Li F, Qu L, Liu Y, Wu X, Qi X, Wang J, Zhu H, Yang F, Shen Z, Guo Y, Zhang Y, Yu J, Mao R, Zhang Q, Zhang F, Chen L, Huang Y, Zhang X, Li Q, Zhang W, Zhang J.
Li F, et al. Among authors: zhang q, zhang f, zhang w, zhang j, zhang x, zhang y.
J Hepatol. 2024 Jul 31:S0168-8278(24)02426-7. doi: 10.1016/j.jhep.2024.07.019. Online ahead of print.
J Hepatol. 2024.
PMID: 39094743